**Core Concept**
The anionic site of acetylcholinesterase (AChE) is a critical region for the binding of certain drugs, which can either inhibit or enhance the enzyme's activity. This site is distinct from the active site, where acetylcholine (ACh) is hydrolyzed, and is responsible for the allosteric modulation of enzyme activity.

**Why the Correct Answer is Right**
The correct answer, **neostigmine**, binds specifically to the anionic site of AChE, increasing the enzyme's affinity for ACh and thus potentiating its effects. This is because neostigmine is a carbamate that forms a covalent bond with the anionic site, leading to an increase in the enzyme's activity. This specific binding to the anionic site is unique to neostigmine among the available options.

**Why Each Wrong Option is Incorrect**
* **Option A:** Edrophonium, a fast-acting cholinesterase inhibitor, primarily acts by competing with ACh for the active site, rather than binding to the anionic site.
* **Option B:** Physostigmine, another cholinesterase inhibitor, works by binding to both the active and anionic sites, making it less specific than neostigmine.
* **Option D:** Pyridostigmine, a long-acting cholinesterase inhibitor, also acts by competing with ACh for the active site, similar to edrophonium.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that neostigmine is often used to reverse non-depolarizing muscle relaxants in clinical settings, highlighting the importance of its unique pharmacological profile.

**Correct Answer:** A. Neostigmine.